Vis enkel innførsel

dc.contributor.authorBrekke, Kurt Richard
dc.contributor.authorStraume, Odd Rune
dc.contributor.authorHolmås, Tor Helge
dc.date.accessioned2010-10-19T11:48:17Z
dc.date.available2010-10-19T11:48:17Z
dc.date.issued2010-07
dc.identifier.issn0804-6824
dc.identifier.urihttp://hdl.handle.net/11250/163262
dc.description.abstractWe study the impact of product margins on pharmacies incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies substitution incentives are determined by relative margins and relative patient copayments. Second, we exploit a unique product level panel data set, which contains information on sales and prices at both producer and retail level. In the empirical analysis, we find a strong relationship between the margins of brand-names and generics and their market shares. In terms of policy implications, our results suggest that pharmacy incentives are crucial for promoting generic sales.en
dc.language.isoengen
dc.publisherNorwegian School of Economics and Business Administration. Department of Economicsen
dc.relation.ispartofseriesDiscussion paperen
dc.relation.ispartofseries2010:18en
dc.subjectpharmaceuticalsen
dc.subjectpharmaciesen
dc.subjectgeneric substitutionen
dc.titleMargins and market shares : pharmacy incentives for generic substitutionen
dc.typeWorking paperen
dc.subject.nsiVDP::Samfunnsvitenskap: 200::Økonomi: 210en


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel